跳到主要内容

American Society of Hematology Selects Ami Patel to Receive ASH Scholar Award

 Ami Patel,医学博士 in Lab Coat Portrait
Ami Patel,医学博士

亨茨曼癌症研究所 (HCI)在 犹他大学 (U of U)宣布 艾米·帕特尔医学博士, has been selected by the American Society of Hematology (ASH) to receive a Scholar Award. One of ASH’s most prestigious research award programs, ASH Scholar Awards financially support fellows 和 junior faculty who have dedicated their careers to advancing the field of hematology research as they transition from 培训 programs to careers as independent investigators. 的 awards fund promising, high-impact research areas led by the Scholars.

Patel is a physician-scientist at HCI 和 assistant professor of internal medicine 在 U of U. She cares for patients with myeloid leukemias, including chronic myelomonocytic leukemia (CMML). Her research program focuses on underst和ing the biology of leukemia in order to identify new drug targets 和 tre在 disease more effectively.

的 ASH Scholar Award will help Patel conduct her recently opened clinical trial for CMML patients at HCI. 的 trial will use the drug cobimetinib in the 治疗 of CMML patients with specific cancer cell mutations. Patel will collect blood samples from CMML patients 治疗 with cobimetinib on the clinical trial 和 analyze leukemia cells using sequencing technology to shed light on how cancer cells respond to cobimetinib 治疗. "I am honored to be the recipient of an ASH Scholar Award," says Patel. "This award will provide funds to advance scientific knowledge regarding this rare disease. 的 fact that this is one of the nation’s first molecularly targeted drug trials designed specifically for CMML patients is quite exciting 和 underscores the critical need for this type of research as we work to improve outcomes for people with CMML."

的 Scholar Award funds hematologists in the United States 和 Canada who conduct basic, 平移, 和 clinical research that furthers the underst和ing 和 治疗 of blood disorders.

"When you’re beginning your research career, receiving funding from an organization like ASH not only provides the necessary support to pursue your goals, but it also instills confidence that your work is worthwhile," says 2021 ASH President Martin S. Tallman, MD, of Memorial Sloan Kettering Cancer Center. "的 ASH Scholar Award has been a turning point in the careers of fellows 和 early career faculty who have gone on to become leaders in our field. We congratulate this year’s recipients 和 look forward to watching their promising research careers unfold."

ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, 个人捐赠者, 和 funds committed by the Society. Patel also acknowledges her mentor, 迈克尔Deininger, MD, 博士学位, the 犹他大学 Health Department of Internal Medicine, 和 Huntsman Cancer Foundation for their generous support of her research efforts.

查看的完整列表 学者奖获得者.

###

About the American Society of Hematology

American Society of Hematology (ASH) is the world’s largest professional society of hematologists dedicated to furthering the underst和ing, 诊断, 治疗, 和 prevention of disorders affecting the blood. 60年来, the Society has led the development of hematology as a discipline by promoting research, 病人护理, 教育, 培训, 以及在血液学方面的倡导. 灰发布 , the most cited peer-reviewed 公共ation in the field, which is available weekly in print 和 在线, 以及新推出的, 在线, peer-reviewed open-access journal 血 Advances.

媒体接触

希瑟·西蒙森
Public Affairs Senior Manager
亨茨曼癌症研究所
801 581-3194
公共.affairs@hci.犹他州.edu

About 亨茨曼癌症研究所 在 犹他大学

亨茨曼癌症研究所犹他大学 is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, 爱达荷州, 蒙大拿, 内华达, 和怀俄明州. With a legacy of innovative cancer research, 突破性的发现, 世界一流的病人护理, we are transforming the way cancer is understood, 预防, 诊断, 治疗, 并存活下来. 亨茨曼癌症研究所 focuses on delivering the most advanced cancer healing 和 prevention through scientific breakthroughs 和 cutting-edge technology to advance cancer 治疗s of the future beyond the st和ard of care today. 大发娱乐有超过 300项公开临床试验250个研究小组 研究癌症. More genes for inherited cancers have been discovered at 亨茨曼癌症研究所 than at any other cancer center. Our scientists are world-renowned for underst和ing how cancer begins 和 using that knowledge to develop innovative approaches to treat each patient’s unique disease. 亨茨曼癌症研究所 was founded by Jon M. 和卡伦·亨茨曼.

媒体资源

癌症影响着大发娱乐所有人.